These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36248979)

  • 61. A subregion-based prediction model for local-regional recurrence risk in head and neck squamous cell carcinoma.
    Pan Z; Men K; Liang B; Song Z; Wu R; Dai J
    Radiother Oncol; 2023 Jul; 184():109684. PubMed ID: 37120101
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Outcome prediction of head and neck squamous cell carcinoma by MRI radiomic signatures.
    Mes SW; van Velden FHP; Peltenburg B; Peeters CFW; Te Beest DE; van de Wiel MA; Mekke J; Mulder DC; Martens RM; Castelijns JA; Pameijer FA; de Bree R; Boellaard R; Leemans CR; Brakenhoff RH; de Graaf P
    Eur Radiol; 2020 Nov; 30(11):6311-6321. PubMed ID: 32500196
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prediction of radiation pneumonitis after definitive radiotherapy for locally advanced non-small cell lung cancer using multi-region radiomics analysis.
    Kawahara D; Imano N; Nishioka R; Ogawa K; Kimura T; Nakashima T; Iwamoto H; Fujitaka K; Hattori N; Nagata Y
    Sci Rep; 2021 Aug; 11(1):16232. PubMed ID: 34376721
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Performance of
    Zhang M; Bao Y; Rui W; Shangguan C; Liu J; Xu J; Lin X; Zhang M; Huang X; Zhou Y; Qu Q; Meng H; Qian D; Li B
    Front Oncol; 2020; 10():568857. PubMed ID: 33134170
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Radiomics-driven personalized radiotherapy for primary and recurrent tumors: A general review with a focus on reirradiation.
    Beddok A; Orlhac F; Rozenblum L; Calugaru V; Créhange G; Dercle L; Nioche C; Thariat J; Marin T; El Fakhri G; Buvat I
    Cancer Radiother; 2024 Nov; 28(6-7):597-602. PubMed ID: 39406602
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clinical parameters combined with radiomics features of PET/CT can predict recurrence in patients with high-risk pediatric neuroblastoma.
    Feng L; Qian L; Yang S; Ren Q; Zhang S; Qin H; Wang W; Wang C; Zhang H; Yang J
    BMC Med Imaging; 2022 May; 22(1):102. PubMed ID: 35643445
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Optimal batch determination for improved harmonization and prognostication of multi-center PET/CT radiomics feature in head and neck cancer.
    Wu H; Liu X; Peng L; Yang Y; Zhou Z; Du D; Xu H; Lv W; Lu L
    Phys Med Biol; 2023 Nov; 68(22):. PubMed ID: 37844604
    [No Abstract]   [Full Text] [Related]  

  • 68.
    Li P; Wang X; Xu C; Liu C; Zheng C; Fulham MJ; Feng D; Wang L; Song S; Huang G
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1116-1126. PubMed ID: 31982990
    [TBL] [Abstract][Full Text] [Related]  

  • 69. External validation of nodal failure prediction models including radiomics in head and neck cancer.
    Zhai TT; Wesseling F; Langendijk JA; Shi Z; Kalendralis P; van Dijk LV; Hoebers F; Steenbakkers RJHM; Dekker A; Wee L; Sijtsema NM
    Oral Oncol; 2021 Jan; 112():105083. PubMed ID: 33189001
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Additional value of metabolic parameters to PET/CT-based radiomics nomogram in predicting lymphovascular invasion and outcome in lung adenocarcinoma.
    Nie P; Yang G; Wang N; Yan L; Miao W; Duan Y; Wang Y; Gong A; Zhao Y; Wu J; Zhang C; Wang M; Cui J; Yu M; Li D; Sun Y; Wang Y; Wang Z
    Eur J Nucl Med Mol Imaging; 2021 Jan; 48(1):217-230. PubMed ID: 32451603
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Image Guided Radiotherapy (IGRT) and Delta (Δ) Radiomics-An Urgent Alliance for the Front Line of the War against Head and Neck Cancers.
    Mireștean CC; Iancu RI; Iancu DPT
    Diagnostics (Basel); 2023 Jun; 13(12):. PubMed ID: 37370940
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prediction of survival outcome based on clinical features and pretreatment
    Ghosh S; Maulik S; Chatterjee S; Mallick I; Chakravorty N; Mukherjee J
    Comput Methods Programs Biomed; 2020 Oct; 195():105669. PubMed ID: 32763771
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Radiomic Features at Contrast-enhanced CT Predict Recurrence in Early Stage Hepatocellular Carcinoma: A Multi-Institutional Study.
    Ji GW; Zhu FP; Xu Q; Wang K; Wu MY; Tang WW; Li XC; Wang XH
    Radiology; 2020 Mar; 294(3):568-579. PubMed ID: 31934830
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Radiomics in Gastric Cancer: First Clinical Investigation to Predict Lymph Vascular Invasion and Survival Outcome Using
    Yang L; Chu W; Li M; Xu P; Wang M; Peng M; Wang K; Zhang L
    Front Oncol; 2022; 12():836098. PubMed ID: 35433451
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Radiomic analysis for predicting prognosis of colorectal cancer from preoperative
    Lv L; Xin B; Hao Y; Yang Z; Xu J; Wang L; Wang X; Song S; Guo X
    J Transl Med; 2022 Feb; 20(1):66. PubMed ID: 35109864
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Radiomics signature from [
    Jiang C; Huang X; Li A; Teng Y; Ding C; Chen J; Xu J; Zhou Z
    Eur Radiol; 2022 Aug; 32(8):5730-5741. PubMed ID: 35298676
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Imbalanced Data Correction Based PET/CT Radiomics Model for Predicting Lymph Node Metastasis in Clinical Stage T1 Lung Adenocarcinoma.
    Lv J; Chen X; Liu X; Du D; Lv W; Lu L; Wu H
    Front Oncol; 2022; 12():788968. PubMed ID: 35155231
    [TBL] [Abstract][Full Text] [Related]  

  • 78.
    Jiang C; Zhao L; Xin B; Ma G; Wang X; Song S
    Quant Imaging Med Surg; 2022 Aug; 12(8):4135-4150. PubMed ID: 35919043
    [TBL] [Abstract][Full Text] [Related]  

  • 79. CT-based radiomics signatures can predict the tumor response of non-small cell lung cancer patients treated with first-line chemotherapy and targeted therapy.
    Yang F; Zhang J; Zhou L; Xia W; Zhang R; Wei H; Feng J; Zhao X; Jian J; Gao X; Yuan S
    Eur Radiol; 2022 Mar; 32(3):1538-1547. PubMed ID: 34564744
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Application of radiomics for the prediction of HPV status for patients with head and neck cancers.
    Bagher-Ebadian H; Lu M; Siddiqui F; Ghanem AI; Wen N; Wu Q; Liu C; Movsas B; Chetty IJ
    Med Phys; 2020 Feb; 47(2):563-575. PubMed ID: 31853980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.